USD $42.62
GLYCOMET TRIO is a combination medication designed to manage blood sugar levels in individuals with type 2 diabetes. It integrates three active ingredients to provide a comprehensive approach to diabetes management, aiding in improved glycemic control.
GLYCOMET TRIO combines the effects of Metformin, Glimepiride, and Pioglitazone. Metformin reduces glucose production in the liver, Glimepiride stimulates insulin release from the pancreas, and Pioglitazone enhances insulin sensitivity. Together, these mechanisms help maintain balanced blood sugar levels.
This medication is intended for adults diagnosed with type 2 diabetes who require a combination therapy to control their blood sugar levels. It is typically prescribed when single-drug therapy is insufficient.
GLYCOMET TRIO should be taken as prescribed by a healthcare provider. It is usually administered orally with meals to reduce gastrointestinal side effects. Adherence to the prescribed dosage schedule is crucial for optimal results.
Common side effects may include gastrointestinal symptoms such as nausea or diarrhea, dizziness, or hypoglycemia. It is important to discuss any adverse effects with a healthcare provider.
Interactions with other drugs can occur, so it is essential to inform the healthcare provider of all medications being taken. This includes over-the-counter drugs and supplements.
Individuals should monitor their blood sugar levels regularly and follow dietary and exercise recommendations. Regular medical check-ups are advised to assess the medication's effectiveness and adjust dosages if necessary.
For further details, consult a healthcare professional or refer to the medication guide provided with the prescription. Always follow the directions and advice given by the healthcare provider to ensure safe and effective use of GLYCOMET TRIO.
Health Guides